Pamidronate (Aredia™) is exclusively administered intravenously.

Its indications are somewhat broader


The usual dosage is around 90 mg per cure which should be renewed every 4 weeks (except for hypercalcaemia where strict supervision should be instituted). The intravenous administration should last 2 to 3 hours.

During infusion, fever may be observed (delayed fever can also occur) as well as flu-like syndrome, local reactions, bone pains, myalgias. All of these side effects are generally mild.

Access to main chapter